you are viewing a single comment's thread.
Dooper - should we expect a press release from Omeros on this? Would think so if signficant
LOL, I was wrong. They issue a PR minutes ago.http://www.prnewswire.com/news-releases/omeros-announces-publication-of-masp-2-data-in-proceedings-of-the-national-academy-of-sciences-120191324.html
You scooped 'em, Dooper!
bizzman1, I tend to doubt it since these are preclinical results. But, to me, it sounds very interesting because if it works out in clinical trials, the implications are significant IMO.